NASDAQ:OMCL Omnicell (OMCL) Stock Price, News & Analysis $29.31 +0.02 (+0.07%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$29.13▼$30.2750-Day Range$25.61▼$32.6552-Week Range$25.12▼$66.65Volume242,085 shsAverage Volume475,712 shsMarket Capitalization$1.35 billionP/E RatioN/ADividend YieldN/APrice Target$42.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Omnicell alerts: Email Address Omnicell MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside44.0% Upside$42.20 Price TargetShort InterestBearish4.55% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.11Based on 14 Articles This WeekInsider TradingN/AProj. Earnings Growth84.62%From $0.26 to $0.48 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.09 out of 5 starsMedical Sector392nd out of 936 stocksElectronic Computers Industry4th out of 6 stocks 3.2 Analyst's Opinion Consensus RatingOmnicell has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageOmnicell has only been the subject of 1 research reports in the past 90 days.Read more about Omnicell's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.55% of the outstanding shares of Omnicell have been sold short.Short Interest Ratio / Days to CoverOmnicell has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Omnicell has recently increased by 8.85%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOmnicell does not currently pay a dividend.Dividend GrowthOmnicell does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OMCL. Previous Next 3.9 News and Social Media Coverage News SentimentOmnicell has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Omnicell this week, compared to 3 articles on an average week.Search Interest4 people have searched for OMCL on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat Follows4 people have added Omnicell to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Omnicell insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.64% of the stock of Omnicell is held by insiders.Percentage Held by Institutions97.70% of the stock of Omnicell is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Omnicell's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Omnicell are expected to grow by 84.62% in the coming year, from $0.26 to $0.48 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Omnicell is -63.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Omnicell is -63.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioOmnicell has a PEG Ratio of 80.80. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioOmnicell has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Omnicell's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. About Omnicell Stock (NASDAQ:OMCL)Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.Read More OMCL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OMCL Stock News HeadlinesJuly 27 at 1:40 AM | americanbankingnews.comQ2 2024 Earnings Forecast for Omnicell, Inc. Issued By Zacks Research (NASDAQ:OMCL)July 26 at 2:57 AM | americanbankingnews.comQ1 2025 EPS Estimates for Omnicell, Inc. (NASDAQ:OMCL) Increased by AnalystJuly 27, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.July 25 at 11:11 AM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Argenx Se (ARGX)July 24 at 7:50 AM | investorplace.com3 Russell 2000 Stocks to Buy at a 52-week Low in JulyJuly 17, 2024 | americanbankingnews.comOmnicell (NASDAQ:OMCL) Lowered to "Hold" at StockNews.comMay 25, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of Omnicell, Inc. (NASDAQ:OMCL)May 17, 2024 | markets.businessinsider.comBuy Rating on Omnicell Affirmed: Innovation and Growth Outlook Fuel Optimism for FY24 and BeyondJuly 27, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.May 8, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Omnicell (OMCL)May 6, 2024 | businesswire.comOmnicell Supports Global Charity Mercy Ships with Pharmacy Technology DonationMay 3, 2024 | finance.yahoo.comOmnicell, Inc. (NASDAQ:OMCL) Q1 2024 Earnings Call TranscriptMay 3, 2024 | businesswire.comOmnicell to Present at the BofA Securities 2024 Health Care ConferenceMay 3, 2024 | finance.yahoo.comOmnicell Inc (OMCL) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...May 3, 2024 | seekingalpha.comLeMaitre Vascular declares $0.16 dividendMay 3, 2024 | finance.yahoo.comQ1 2024 Omnicell Inc Earnings CallMay 2, 2024 | finance.yahoo.comOmnicell Inc (OMCL) Q1 2024 Earnings Analysis: Challenges Persist Amid Revenue DeclineMay 2, 2024 | investorplace.comOMCL Stock Earnings: Omnicell Beats EPS, Beats Revenue for Q1 2024See More Headlines Receive OMCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electronic computers Sub-IndustryHealth Care Technology Current SymbolNASDAQ:OMCL CUSIP68213N10 CIK926326 Webwww.omnicell.com Phone(877) 415-9990Fax847-596-3402Employees3,650Year Founded1992Price Target and Rating Average Stock Price Target$42.20 High Stock Price Target$75.00 Low Stock Price Target$26.00 Potential Upside/Downside+44.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.46) Trailing P/E RatioN/A Forward P/E Ratio112.73 P/E Growth80.8Net Income$-20,370,000.00 Net Margins-1.91% Pretax Margin-1.52% Return on Equity2.41% Return on Assets1.28% Debt Debt-to-Equity Ratio0.48 Current Ratio2.38 Quick Ratio2.13 Sales & Book Value Annual Sales$1.15 billion Price / Sales1.17 Cash Flow$3.11 per share Price / Cash Flow9.42 Book Value$26.15 per share Price / Book1.12Miscellaneous Outstanding Shares45,920,000Free Float44,711,000Market Cap$1.35 billion OptionableOptionable Beta0.80 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Randall A. Lipps (Age 67)Founder, Executive Chairman, President & CEO Comp: $1.85MMr. Nchacha E. Etta (Age 52)Executive VP & CFO Comp: $480.21kMr. Corey J. Manley (Age 46)Executive VP, Chief Legal & Administrative Officer and Corporate Secretary Comp: $715.33kMs. Minoo MortazaviSenior Vice President of Global OperationsMr. Brian H. Nutt (Age 54)VP, Chief Accounting Officer & Corporate Controller Mr. Giri ChodavarapuSenior VP & Chief Information OfficerMs. Kathleen NemethSenior Vice President of Investor RelationsMr. Maximo RochaSenior VP & Chief People OfficerMr. Joseph Brian Spears (Age 64)Executive Adviser Ms. Sara DalmassoSenior VP & GM of InternationalMore ExecutivesKey CompetitorsVeradigmNASDAQ:MDRXFitbitNYSE:FITHealthStreamNASDAQ:HSTMHuamiNYSE:HMICortexymeNASDAQ:CRTXView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpSold 199,796 shares on 7/26/2024Ownership: 2.373%Liontrust Investment Partners LLPBought 150,210 shares on 7/26/2024Ownership: 0.327%GAM Holding AGSold 15,385 shares on 7/26/2024Ownership: 0.179%Louisiana State Employees Retirement SystemBought 600 shares on 7/24/2024Ownership: 0.050%Nisa Investment Advisors LLCBought 1,000 shares on 7/20/2024Ownership: 0.003%View All Institutional Transactions OMCL Stock Analysis - Frequently Asked Questions How have OMCL shares performed this year? Omnicell's stock was trading at $37.63 at the start of the year. Since then, OMCL stock has decreased by 22.1% and is now trading at $29.31. View the best growth stocks for 2024 here. How were Omnicell's earnings last quarter? Omnicell, Inc. (NASDAQ:OMCL) announced its earnings results on Thursday, May, 2nd. The company reported ($0.14) EPS for the quarter, topping analysts' consensus estimates of ($0.31) by $0.17. The business had revenue of $246.15 million for the quarter, compared to analyst estimates of $235.70 million. Omnicell had a positive trailing twelve-month return on equity of 2.41% and a negative net margin of 1.91%. What is Randall A. Lipps' approval rating as Omnicell's CEO? 150 employees have rated Omnicell Chief Executive Officer Randall A. Lipps on Glassdoor.com. Randall A. Lipps has an approval rating of 68% among the company's employees. Does Omnicell have any subsidiaries? Omnicell subsidiaries include these companies: MarkeTouch Media LLC, ReCept Pharmacy, FDS Amplicare, 340B Link Business, InPharmics, Ateb Inc., Aesynt, and others. Who are Omnicell's major shareholders? Top institutional shareholders of Omnicell include Bank of New York Mellon Corp (2.37%), Assenagon Asset Management S.A. (1.31%), Liontrust Investment Partners LLP (0.33%) and GAM Holding AG (0.18%). Insiders that own company stock include Randall A Lipps, Peter J Kuipers, Scott Peter Seidelmann, Joanne B Bauer, James T Judson, Christine Marie Mellon, Joseph Brian Spears, Robin Gene Seim and Dan S Johnston. View institutional ownership trends. How do I buy shares of Omnicell? Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Omnicell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Adobe (ADBE), Micron Technology (MU) and NVIDIA (NVDA). This page (NASDAQ:OMCL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OMCL Stock Alerts